Synthesis and Antimicrobial Activity of Polymethacryloylsulfadiazine

Polymethacryloylsulfadiazine의 합성과 항균활성

  • Kim, Sun-Il (Department of Chemical Engineering, Chosun University) ;
  • Na, Jae-Woon (Department of Chemical Engineering, Chosun University) ;
  • Yun, Young-Jae (Department of Chemical Engineering, Chosun University) ;
  • Choi, kyong-Rai (Department of Chemical Engineering, Chosun University)
  • 김선일 (조선대학교 공과대학 화학공학과) ;
  • 나재운 (조선대학교 공과대학 화학공학과) ;
  • 윤영재 (조선대학교 공과대학 화학공학과) ;
  • 최경례 (조선대학교 공과대학 화학공학과)
  • Published : 19950900

Abstract

The synthetic procedures to synthesize polymethacryloylsulfadiazine were searched by DCC method and Acid Chloride mothod. Polymeric drug was synthesized by Acid Chloride method in high yield (72%) but DCC method in low yield (23%). The antimicrobial activities of polymeric drug were investigated in terms of minimum inhibitory concentrations by the common two-fold dilution technique. Polymeric drug revealed an excellent antimicrobial Bacillus subtillis ATCC 6633, Mycrobacterium phlei IFO 3158, Micrococus luteus ATCC 9341, Salmonella typhimurium KCTC 1925, Klebsiella pneumoniae KCTC 1560 and similar activity against Staphylococcus aureus IFO 12732, Escherichia coli BE 1186, Escherichia coli AB 0111, Pseudomonas aeruginosa IFO 13130. Polymeric drug have no antimicrobial activity against Candida albicans IFO 1594.

Keywords

References

  1. Sheets, D. USP 3660353 Wang, C.
  2. J. Polym. Sci. v.3 Cornell, R. J.;Donaruma, L. G.
  3. J. Med. Chem. v.10 Ascoli, F.;Casinit, G.;Ferappi, M.;Tubaro, E.
  4. J. Kor. Chem. Soc. v.37 Yu, E. K.;Kwun, K. H.;Cha, W. S.;Na, J. W.
  5. J. Am. Chem. Soc. v.78 Blout, E. R.;Karlson, R. H.
  6. Nature v.232 Smith, H.;Marshall, A. C.
  7. Principal of Polymer systems Rodriguez, F.
  8. Polymer Handbook Brandrup, J.;Immergut, E. H.
  9. Polymeric Drugs Guy Donaruma, L.;Otto, V.
  10. Brit. J. Exp. Pathol. v.10 Fleming, A.
  11. J. Am. Chem. Soc. v.84 Morin, R. B.;Jackson, B. G.;Flynn, E. H.;Poeske, R. W.
  12. Chemotherapy v.14 Erika, Bohni, B. F.;Rieder, J.;Schaerer K.;Havas, L.
  13. J. Med. Chem. v.5 Lesher, G. Y.;Froelich, E. J.;Gruett, E. D.;Bailey, J. H.;Brundaga, P. R.
  14. Medical Application of Controlled Release v.2 Langer, R. S.;Wise, D. L.
  15. J. Med. Chem. v.8 Cornell, R. J.;Donaruma, L. G.
  16. USP 2407966 Sprague, J. M.;Hill, D.
  17. J. Polym. Sci. v.13 Ferruti, P.;Vaccaroni, F.
  18. 醫藥 高分子 竹本喜一;田伏岩夫
  19. Drug Delievery Systems Lioyd-Jones, J. G.
  20. J. Antibiot v.31 Tanayama, S. T.;Kondo;Kania, Y.
  21. Drug Delivery Systems Johnson, P.;Lioyd-Jones, J. G.
  22. J. Biomed. Mater. Res. v.17 Buckles, R. G.
  23. J. Am. Chem. Soc. v.84 Chauvette, R. R.;Flynn, E. H.;Jackson, B. G.;Lavagnino, E. R.;Morin, R B.;Mueller, R. A.;Pioch, R. P.;Roeske, R. W.;Ryan, C. W.;Spencer, J. L.;Van Heyningen, E.
  24. J. Kor. Chem. Soc. v.36 Kim, S. I.;Cha, W. S.;Na, J. W.;Kim, Y. H.;Ko, O. H.
  25. Yakhak Hoeji v.34 Kim, Y. S.;Ko, O. H.;Kang, H. R.